BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 17206080)

  • 1. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
    Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
    Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extraintestinal manifestations in Crohn's disease: risk factors and influence of intestinal surgery].
    Nascimbeni R; Di Fabio F; Lanzini A; Lanzarotto F; Ricci C; Casella C; Salerni B
    Ann Ital Chir; 2009; 80(4):293-8. PubMed ID: 19967888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
    Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A
    Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.
    Ernst A; Jacobsen B; Østergaard M; Okkels H; Andersen V; Dagiliene E; Pedersen IS; Thorsgaard N; Drewes AM; Krarup HB
    Scand J Gastroenterol; 2007 Dec; 42(12):1445-51. PubMed ID: 17852840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation.
    Büning C; Genschel J; Bühner S; Krüger S; Kling K; Dignass A; Baier P; Bochow B; Ockenga J; Schmidt HH; Lochs H
    Aliment Pharmacol Ther; 2004 May; 19(10):1073-8. PubMed ID: 15142196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
    Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Piu J; Reverter JC; Pique JM; Yagüe J; Panés J
    Aliment Pharmacol Ther; 2007 Feb; 25(4):429-40. PubMed ID: 17269998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
    Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
    Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARD15 mutations in patients with Crohn's disease in a homogeneous Spanish population.
    Núñez C; Barreiro M; Domínguez-Muñoz JE; Lorenzo A; Zapata C; Peña AS
    Am J Gastroenterol; 2004 Mar; 99(3):450-6. PubMed ID: 15056084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications.
    Rankin GB; Watts HD; Melnyk CS; Kelley ML
    Gastroenterology; 1979 Oct; 77(4 Pt 2):914-20. PubMed ID: 467943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis.
    Brant SR; Wang MH; Rawsthorne P; Sargent M; Datta LW; Nouvet F; Shugart YY; Bernstein CN
    Am J Gastroenterol; 2007 Feb; 102(2):313-23. PubMed ID: 17100976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CARD15 mutations and smoking in the course of Crohn's disease in a Mediterranean area.
    Renda MC; Orlando A; Civitavecchia G; Criscuoli V; Maggio A; Mocciaro F; Rossi F; Scimeca D; Modesto I; Oliva L; Cottone M
    Am J Gastroenterol; 2008 Mar; 103(3):649-55. PubMed ID: 18341489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
    Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
    Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of association between precolectomy thrombocytosis and the occurrence of inflammatory pouch disorders.
    Lian L; Fazio VW; Lavery IC; Hammel J; Remzi FH; Shen B
    Dis Colon Rectum; 2009 Nov; 52(11):1912-8. PubMed ID: 19966641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation of Crohn's disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery.
    Lakatos PL; Szalay F; Tulassay Z; Molnar T; Kovacs A; Gasztonyi B; Papp J; Lakatos L;
    Hepatogastroenterology; 2005; 52(63):817-22. PubMed ID: 15966211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.